385 related articles for article (PubMed ID: 25066192)
1. Endothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond GR; Sobey CG
Trends Endocrinol Metab; 2014 Sep; 25(9):452-63. PubMed ID: 25066192
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
Montezano AC; Touyz RM
Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of NADPH oxidase NOX5 in vascular disease.
Jha JC; Watson AMD; Mathew G; de Vos LC; Jandeleit-Dahm K
Clin Sci (Lond); 2017 May; 131(10):981-990. PubMed ID: 28473473
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
5. Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha.
Yoshida LS; Tsunawaki S
Int Immunopharmacol; 2008 Oct; 8(10):1377-85. PubMed ID: 18687299
[TBL] [Abstract][Full Text] [Related]
6. Unchanged NADPH Oxidase Activity in Nox1-Nox2-Nox4 Triple Knockout Mice: What Do NADPH-Stimulated Chemiluminescence Assays Really Detect?
Rezende F; Löwe O; Helfinger V; Prior KK; Walter M; Zukunft S; Fleming I; Weissmann N; Brandes RP; Schröder K
Antioxid Redox Signal; 2016 Mar; 24(7):392-9. PubMed ID: 25906178
[TBL] [Abstract][Full Text] [Related]
7. NOX2 and NOX4 mediate proliferative response in endothelial cells.
Petry A; Djordjevic T; Weitnauer M; Kietzmann T; Hess J; Görlach A
Antioxid Redox Signal; 2006; 8(9-10):1473-84. PubMed ID: 16987004
[TBL] [Abstract][Full Text] [Related]
8. Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.
Rivera J; Sobey CG; Walduck AK; Drummond GR
Redox Rep; 2010; 15(2):50-63. PubMed ID: 20500986
[TBL] [Abstract][Full Text] [Related]
9. Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury.
Braunersreuther V; Montecucco F; Asrih M; Pelli G; Galan K; Frias M; Burger F; Quinderé AL; Montessuit C; Krause KH; Mach F; Jaquet V
J Mol Cell Cardiol; 2013 Nov; 64():99-107. PubMed ID: 24051369
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
Liang CF; Liu JT; Wang Y; Xu A; Vanhoutte PM
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):777-84. PubMed ID: 23413427
[TBL] [Abstract][Full Text] [Related]
11. Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.
Touyz RM; Anagnostopoulou A; Camargo LL; Rios FJ; Montezano AC
Antioxid Redox Signal; 2019 Mar; 30(7):1027-1040. PubMed ID: 30334629
[TBL] [Abstract][Full Text] [Related]
12. A subset of N-substituted phenothiazines inhibits NADPH oxidases.
Seredenina T; Chiriano G; Filippova A; Nayernia Z; Mahiout Z; Fioraso-Cartier L; Plastre O; Scapozza L; Krause KH; Jaquet V
Free Radic Biol Med; 2015 Sep; 86():239-49. PubMed ID: 26013584
[TBL] [Abstract][Full Text] [Related]
13. Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity.
Miller AA; Maxwell KF; Chrissobolis S; Bullen ML; Ku JM; Michael De Silva T; Selemidis S; Hooker EU; Drummond GR; Sobey CG; Kemp-Harper BK
Free Radic Biol Med; 2013 Jul; 60():264-71. PubMed ID: 23459072
[TBL] [Abstract][Full Text] [Related]
14. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Drummond GR; Selemidis S; Griendling KK; Sobey CG
Nat Rev Drug Discov; 2011 Jun; 10(6):453-71. PubMed ID: 21629295
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
16. Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5.
Montezano AC; Burger D; Ceravolo GS; Yusuf H; Montero M; Touyz RM
Clin Sci (Lond); 2011 Feb; 120(4):131-41. PubMed ID: 21039341
[TBL] [Abstract][Full Text] [Related]
17. Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.
Kigawa Y; Miyazaki T; Lei XF; Kim-Kaneyama JR; Miyazaki A
J Atheroscler Thromb; 2017 Jan; 24(1):1-13. PubMed ID: 27476665
[TBL] [Abstract][Full Text] [Related]
18. Suppression of oxidative stress in the endothelium and vascular wall.
Jiang F; Drummond GR; Dusting GJ
Endothelium; 2004; 11(2):79-88. PubMed ID: 15370067
[TBL] [Abstract][Full Text] [Related]
19. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
Guzik TJ; Sadowski J; Kapelak B; Jopek A; Rudzinski P; Pillai R; Korbut R; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1614-20. PubMed ID: 15256399
[TBL] [Abstract][Full Text] [Related]
20. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.
Heumüller S; Wind S; Barbosa-Sicard E; Schmidt HH; Busse R; Schröder K; Brandes RP
Hypertension; 2008 Feb; 51(2):211-7. PubMed ID: 18086956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
